跳至主要内容
临床试验/CTRI/2024/09/074251
CTRI/2024/09/074251招募中3 期

Prospective single arm open clinical trial to evaluate the efficacy of Punarnavadi Vati in the management of Sthaulya with special reference to Dyslipidemia in Hypertension.

Dr Shweta Santosh Shirsath1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年9月25日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
to evaluate the efficacy of Punarnavadi Vati In Sthaulya with special reference to Dyslipidemia in Hypertension.

研究概览

简要总结

single arm open clinical trial

this study is conducting for To evaluate the efficacy of Punarnavadi Vati In Sthaulya with special reference to Dyslipidemia in Hypertension.

Total 30 patients of Sthaulya with hypertension who fulfils inclusion criteria and showing signs and symptoms will Be taken from OPD and IPD of concerned institute. Written information consent will be taken in native language.

Various epidemiological studies have shown the prevalence of the co-existence of dyslipidemia with hypertension in the range of 15 to 31% and Prevalence in Maharashtra is 34%. As per modern science sthaulya sings and symotoms resembles with dyslipidemia, It is characterised by abnormal level of lipids.

Null Hypothesis

Punarnavadi vati 500mg orally four tablets twice a day for 30 days is not effective in sthaulya with special reference to Dyslipidemia in HTN

Alternative Hypothesis

Punarnavadi vati 500mg orally four tablets twice a day for 30 days is not effective in sthaulya with special reference to Dyslipidemia in HTN

Drug- Punarnavadi Vati

Dose- 500mg 4 tablets twice a day

Anupana- koshna jala

Sevankala : Bhojanpashchat

Duration : 30 Days

Ahara(Diet) : As per pathyakara Ahara mentioned in Ayurvedic texts.

Vihara : As per pathyakara Vihara mentioned in Ayurvedic texts

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1 efficacy of punarnavadi vati in the management of sthaulya with special reference to dyslipidemia in hypertension.
  • 2 Patients from age group of 18 to 60years irrespective of gender, religion, socio-economic status, marital status.
  • 2 Patients of Sthaulya with hypertension as per signs and symptoms BMI between 25 to
  • Including overweight Obese class 1 as per signs and symptoms mentioned in Ayurvedic Samhitas.
  • 3 Waist To hip Ratio more than
  • 4 Patient with known case of HTN Systolic BP should be less than 160 Diastolic BP should be less than 100.

排除标准

  • 1 Pregnant and lactating women.
  • 2 Acute life threatening conditions like CVA, CA, Acute MI, DM I and Insulin Dependent.
  • 3 Known Cases of Hypothyroidism and hyperthyroidism.
  • 4 Patient with Systolic BP more than 160 diastolic BP more than 99.

结局指标

主要结局

to evaluate the efficacy of Punarnavadi Vati In Sthaulya with special reference to Dyslipidemia in Hypertension.

时间窗: 15th and 30th day

次要结局

  • 1 To evaluate the efficacy of Punarnavadi Vati in Sthaulya with special reference to dyslipidemia in HTN.(2 To study the etiopathology of Sthaulya and Dyslipidemia)

研究者

发起方
Dr Shweta Santosh Shirsath
申办方类型
Other [self ]
责任方
Principal Investigator
主要研究者

Dr Shweta Santosh Shirsath

Seth Chandanmal Mutha Aryangla Vaidyak Mahavidyalaya, Satara

研究点 (1)

Loading locations...

相似试验